Xenotransplantation and interspecies organogenesis: current status and issues
- PMID: 35992127
- PMCID: PMC9388829
- DOI: 10.3389/fendo.2022.963282
Xenotransplantation and interspecies organogenesis: current status and issues
Abstract
Pancreas (and islet) transplantation is the only curative treatment for type 1 diabetes patients whose β-cell functions have been abolished. However, the lack of donor organs has been the major hurdle to save a large number of patients. Therefore, transplantation of animal organs is expected to be an alternative method to solve the serious shortage of donor organs. More recently, a method to generate organs from pluripotent stem cells inside the body of other species has been developed. This interspecies organ generation using blastocyst complementation (BC) is expected to be the next-generation regenerative medicine. Here, we describe the recent advances and future prospects for these two approaches.
Keywords: blastocyst complementation; chimera; islet; pancreas; pluripotent stem cells; type 1 diabetes; xenotransplantation.
Copyright © 2022 Kano, Mizutani, Homma, Masaki and Nakauchi.
Conflict of interest statement
HN is a cofounder and shareholder in ReproCELL, Megakaryon, and Century Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Pw W. Notes on diabetes treated with extract and by grafts of sheep’s pancreas. BMJ (1894) 2:1303.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
